Page 1 | Search Results | ASH Clinical News | American Society of Hematology

Skip to Main Content

Advertisement intended for health care professionals

Close

ASH
ASH Clinical News
ASH Image Bank Open External Link
ASH News Daily
ASH-SAP
Blood Journals
Hematology
The Hematologist
International

header search

search input Search input auto suggest

filter your search

Search

Menu

About
Viewpoints
Education
Spotlight
News
Topic Compilations

Skip Nav Destination

Update search

Querybuilder input 1 Querybuilder input

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 2 Querybuilder input

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 3 Querybuilder input

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 4 Querybuilder input

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 5 Querybuilder input

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 6 Querybuilder input

Title
Author
Full Text
Abstract
Keyword
DOI

NARROW

Publications

Filter by publications

ASH Clinical News (731)

Format

Filter by format

News (731)

Topics

Filter by topics

On Location (731)
ASH Annual Meeting (223)
Other Meetings (192)
Lymphomas & Lymphoid Neoplasia (79)
MDS & Myeloproliferative Neoplasms (57)
Acute Leukemias (55)
Multiple Myeloma and Plasma Disorders (54)
Bleeding Disorders (44)
Chronic Leukemias (42)
December 2025 (41)

Date

Filter by date

Date range

Single date

From

To

Apply

Availability

Availability

1-20 of 731

1

Sort by

Sort Order Select

News

Beyond Disease Control: Person-Centered Care Advances Quality of Life in Patients with Hemoglobinopathies

Khylia Marshall

Published: 2025

Abstract

December 2025

View News titled, Beyond Disease Control: Person-Centered Care Advances Quality of Life in Patients with Hemoglobinopathies

News

Azacitidine, Venetoclax Effective as Treatment for Acute Myeloid Leukemia

Lara C. Pullen, PhD

Published: 2025

Abstract

December 2025

View News titled, Azacitidine, Venetoclax Effective as Treatment for Acute Myeloid Leukemia

News

Early Data Indicate Ziftomenib Plus Venetoclax/Azacitidine Effective for NPM1-Mutated AML

Lara C. Pullen, PhD

Published: 2025

Abstract

December 2025

View News titled, Early Data Indicate Ziftomenib Plus Venetoclax/Azacitidine Effective for NPM1-Mutated AML

News

Inferior Survival in Black Patients with AML Is Independent of Cytogenetic Profiles

Lara C. Pullen, PhD

Published: 2025

Abstract

December 2025

View News titled, Inferior Survival in Black Patients with AML Is Independent of Cytogenetic Profiles

News

Quadruplet Plus AHCT Leads to Delayed MRD Negativity but Good Outcomes in t(11;14) MM

Thomas R. Collins

Published: 2025

Abstract

December 2025

View News titled, Quadruplet Plus AHCT Leads to Delayed MRD Negativity but Good Outcomes in t(11;14) MM

News

Cancer-Specific Risk Assessment Model Better at Predicting Hospital-Acquired VTE

Leah Lawrence

Published: 2025

Abstract

December 2025

View News titled, Cancer-Specific Risk Assessment Model Better at Predicting Hospital-Acquired VTE

News

Study Identifies Potential Surrogate Marker for Bleeding Risk in AHA with Emicizumab

Ruth Jessen Hickman, MD

Published: 2025

Abstract

December 2025

View News titled, Study Identifies Potential Surrogate Marker for Bleeding Risk in AHA with Emicizumab

News

Vigilance Needed to Prevent Hemolytic Events When Switching Complement Inhibitors in PNH

Ruth Jessen Hickman, MD

Published: 2025

Abstract

December 2025

View News titled, Vigilance Needed to Prevent Hemolytic Events When Switching Complement Inhibitors in PNH

News

Bifunctional Monoclonal Antibody for PNH Continues to Show Positive Results

Ruth Jessen Hickman, MD

Published: 2025

Abstract

December 2025

View News titled, Bifunctional Monoclonal Antibody for PNH Continues to Show Positive Results

News

siRNA Successfully Targets Complement Factor B in PNH

Ruth Jessen Hickman, MD

Published: 2025

Abstract

December 2025

View News titled, siRNA Successfully Targets Complement Factor B in PNH

News

Risk Factors for Renal Dysfunction in PV Identified

Thomas R. Collins

Published: 2025

Abstract

December 2025

View News titled, Risk Factors for Renal Dysfunction in PV Identified

News

PATHFINDER Four-Year Update: Avapritinib Continues to Deliver Durable, Deep Responses in Advanced Systemic Mastocytosis

Pinky Sharma

Published: 2025

Abstract

December 2025

View News titled, PATHFINDER Four-Year Update: Avapritinib Continues to Deliver Durable, Deep Responses in Advanced Systemic Mastocytosis

News

Bezuclastinib Improves Symptoms, Biomarkers in Nonadvanced Systemic Mastocytosis

Pinky Sharma

Published: 2025

Abstract

December 2025

View News titled, Bezuclastinib Improves Symptoms, Biomarkers in Nonadvanced Systemic Mastocytosis

News

Bezuclastinib Improves Disease Pathology of Systemic Mastocytosis in Phase II Trial

Anna Azvolinsky, PhD

Published: 2025

Abstract

December 2025

View News titled, Bezuclastinib Improves Disease Pathology of Systemic Mastocytosis in Phase II Trial

News

KRd Regimen Achieves Superior Efficacy Over VRd in NDMM Phase III Trial

Anna Azvolinsky, PhD

Published: 2025

Abstract

December 2025

View News titled, KRd Regimen Achieves Superior Efficacy Over VRd in NDMM Phase III Trial

News

Antibody-Based Doublet Effective in Elderly Patients with NDMM

Leah Lawrence

Published: 2025

Abstract

December 2025

View News titled, Antibody-Based Doublet Effective in Elderly Patients with NDMM

News

ROSEWOOD Final Analysis: Combination Zanubrutinib-Obinutuzumab Improves Outcomes Over Obinutuzumab Alone in R/R FL

Khylia Marshall

Published: 2025

Abstract

December 2025

View News titled, ROSEWOOD Final Analysis: Combination Zanubrutinib-Obinutuzumab Improves Outcomes Over Obinutuzumab Alone in R/R FL

News

Fixed-Duration Mosunetuzumab with Lenalidomide Has Benefits for Untreated Indolent Lymphomas

Leah Lawrence

Published: 2025

Abstract

December 2025

View News titled, Fixed-Duration Mosunetuzumab with Lenalidomide Has Benefits for Untreated Indolent Lymphomas

News

Mosunetuzumab Shows Safety, Efficacy as Frontline Therapy in High Tumor Buden Follicular Lymphoma

Khylia Marshall

Published: 2025

Abstract

December 2025

View News titled, Mosunetuzumab Shows Safety, Efficacy as Frontline Therapy in High Tumor Buden Follicular Lymphoma

News

Next-Gen BCL2 Inhibitor Sonrotoclax Shows Good Outcomes in Phase I Trial

Thomas R. Collins

Published: 2025

Abstract

December 2025

View News titled, Next-Gen BCL2 Inhibitor Sonrotoclax Shows Good Outcomes in Phase I Trial

1

About ASH Clinical News
Advertising
Subscribe

Contact Us

American Society of Hematology
2021 L Street NW, Suite 900
Washington, DC 20036
TEL +1 202-776-0544
FAX +1 202-776-0545

ASH Publications

Blood
Blood Advances
Blood Global Hematology
Blood Immunology & Cellular Therapy
Blood Neoplasia
Blood Red Cells & Iron
Blood Vessels, Thrombosis & Hemostasis
Hematology, ASH Education Program
ASH Clinical News
ASH-SAP
The Hematologist

American Society of Hematology

ASH Home
ASH Image Bank
ASH Store

Advocacy
Education
Meetings
Research

Copyright 2025 by American Society of Hematology

Cookie Settings
Privacy Policy
Cookie Policy
Terms of Use
Contact Us

This Feature Is Available To Subscribers Only

Sign In or Create an Account

Advertisement intended for health care professionals